SlideShare une entreprise Scribd logo
1  sur  30
Potential Biowarfare Agents and their
         Methods of Spread

                      Dr Kamran Afzal
          Classified Pathologist and Microbiologist
I. Potential BW Agents
Potential BW Agents: CDC Category A
     FEATURES                       AGENTS

 Easily disseminated or       Anthrax
  transmitted person -         Plague
  person                       Smallpox
 High mortality – major
                               Tularemia
  public health impact         Viral
 Public panic and social
                                     haemorrhagic
                                fevers
  disruption                   Botulinum toxin
 Special action for public
  health preparedness
Potential BW Agents: CDC Category B

     FEATURES                 AGENTS

 Moderately  easy to        Brucellosis
  disseminate
                            Q  fever
 Moderate morbidity, low
  mortality                  Glanders & melioidosis

 Require enhancement of     VEE, EEE and WEE
  diagnostic capacity and    Enteric pathogens
  surveillance
                             Other toxins
Potential BW Agents: CDC Category C

     FEATURES                      AGENTS

 Emerging    agents              Nipah virus
 Availability
                                  Hantaviruses
 Easy to produce and
                                  Tickborne HF
  disseminate
 Potential for high mortality    Tickborne encephalitis

  and morbidity                   Yellow fever

                                  MDR-TB
Desirable Features of Biological Agents to
be used as Biological Weapons
Less expensive
Available
Easily transported/concealed and dispersed
Incubation period “Hides Tracks” of perpetrator
Modifiable (resistance, virulence)
Produce ‘anxiety factor’, over-loading health services
Produce social disruption, reduce productivity
Impact on morale, create epidemic
Characteristics of BW Agent
 Infective dose should be low
 Should be highly contagious
 Should be stable and robust
 Can be aerosolized (1-10 µm)
 Survives sunlight, drying, heat
 Cause lethal or disabling disease
 Person-to-person transmission
 Should consistently produce given effect, death or disease
 Should have a short and predictable incubation period
Characteristics of BW Agent
The agent should be amenable to easy and economical mass
 production
Storage methods should be available
Target population should have little or no natural or acquired immunity
Prophylaxis against the agent should not be available to the target
 population
Little or no treatment for the disease caused by the agent should be
 available
The aggressor should have means to protect its own forces and
 population
Characteristics of BW Agent
It should be capable of efficient dissemination
Stable during dissemination. If it is to be delivered via an aerosol, it
  must survive and remain stable in air until it reaches the target
  population
If it cannot be delivered via an aerosol, living vectors (e.g. fleas,
  mosquitoes or ticks) should be available for dispersal of some form of
  infected substrate
After delivery, the agent should have a low persistence, surviving only
  for a short time, thereby allowing a prompt occupation of the attacked
  area by the aggressor’s troops
Aerosol : Infectivity Relationship
                                                                  Particle Size Infection
    The ideal aerosol                                             (Micron, Mass  Severity
                                                                      Median
contains a homogeneous                                              Diameter)     Less
        population                                                               Severe
     of 2 or 3 micron                                                18-20
 particulates that contain
       one or more                                                   15-18
    viable organisms                                                  7-12

    Maximum human                                                     4-6
                                                                  (bronchioles)
 respiratory infection is a
 particle that falls within                                       1-5 (alveoli)
    1 to 5 micron size                                                             More
                                                                                  Severe

                              Source: San Diego Medical Society
Uniqueness of Biological Attacks
 Responders – medical
 Response System – untested
 Medical System may be a target
 Biological
     Onset - incubation, primary cases
     Secondary cases – contagiousness, contamination
Difficulties in use
Incubation period ranges from hours to days
Rain, sunlight and temp extremes reduce the virulence
Natural and acquired immunity against pathogens make it impossible
  to predict the exact number of casualties from any BW attack
Consequently, BW today is primarily for harassment and special
  operations
Potential BW Agents
Bacteria                      Mode of        I.P.   Mortality   Vaccine    Treatment
                              Transmission

Bacillus anthracis            A, D, I        1–7    5-100       +              E
(Anthrax)

Brucella group                A, D, I        5-21   2-6         +              E
(Brucellosis)
Francisella tularensis        A, D, I, V     1-10   <30         ++             E
(Tularemia)
Yersinia pestis               A, V           2-6    25-100      +++            E
(Plague)
Vibrio cholerae (Cholera)     I              1-5    15-90       +++            E
Corynebacterium diphtheriae   A, D           2-5    5-12        +++            E
(Diphtheria)

A - Aerosol D - Direct contact      I - Ingestion V - Vector    E     - Effective
treatment available N - Non-specific treatment
Potential BW Agents
Salmonella typhi                  I       6-21    7-14          +++             E
(Typhoid fever)
Rickettsiae                       V       6-15    10-40         +++             E
Rickettsia prowazeki
(Epidemic or louse-borne typhyus)
Rickettsia mooseri                V       6-14    2-5                           E
(Endemic or flea-borne typhyus)                                 -

Rickettsia rickettsii             V       3-10    30 (Approx)                   E
(Rocky Mountain spotted fever)                                  -

Coxiella burneti                  A, I    14-21   <1            ++             E
(Q fever)

A - Aerosol D - Direct contact       I - Ingestion V - Vector         E   - Effective
treatment available N - Non-specific treatment
Potential BW Agents
Viruses                             Mode of      I.P. Mortality    Vaccine    Treatment
                                    Transmission
Group A Arboviruses                 V              4-24 60         -               N
Eastern equine encephalitis (EEE)                       (Approx)

 Venezuelan equine encephalitis     V              4-24 <1         ++              N
   (VEE)
Group B Arboviruses                 V (mosquito)   4-24   -        -               N
 St. Louis encephalitis
 Japanese B encephalitis            V (mosquito)   5-15 10-80      ++              N

 Russian spring-summer              V (tick)       7-14 3-40       +               N
 encephalitis (RSSE)
 Yellow fever                       V (mosquito)   3-6    5-40     +++             N


A - Aerosol D - Direct contact       I - Ingestion V - Vector      E     - Effective
treatment available N - Non-specific treatment
Potential BW Agents
Dengue virus                V (mosquito)   4-10    <1           -               N

Ungrouped Arbovirus         V (mosquito)   4-6     1            -               N
Rift Valley fever virus

Poxvirus                    A, D           7-16    1-35         +++             N
Variola virus (Smallpox)

Myxovirus                   A, D           6-365   100          ++              E
Rabies virus

Influenza virus             A, D           1-2     -            +
H5N1                                                                            E



A - Aerosol D - Direct contact       I - Ingestion V - Vector         E   - Effective
treatment available N - Non-specific treatment
Potential BW Agents
Fungi                   A, D       10-21        1-51        -   E
Coccidioides immitis
(Coccidioidomycosis)

Histoplasma               A         5-18         -          -   E
capsulatum




A - Aerosol D - Direct contact       I - Ingestion V - Vector
E - Effective treatment available N - Non-specific treatment
Potential BW Toxins
        NAME                   SOURCE                      EFFECTS

Botulinum toxin A     Clostridium botulinum   Dizziness, sore throat, and dry mouth
                                                  followed by paralysis
                                              Death by suffocation (respiratory
                                                  paralysis) or heart failure

Ricin                 Castor bean plant       Nausea, vomiting, bloody diarrhea, and
                                                  drowsiness
                                              Death by kidney failure (uremia)

Saxitoxin             Dino-flagellates        Tingling around face, loss of sensation
(Shellfish toxin)                                 in extremities
                                              Death by paralysis

Tricothecenes-        Fungus                  Nausea, vomiting, diarrhea
myco toxins                                   Death by internal hemorrhaging
Comparison of Bioterrorism
     Toxins and Chemical Agents
Toxins                   Chemical
Natural origin           Man-made
Generally more toxic     Generally less toxic
Difficult, small-scale   Large-scale, industrial
production               production

None volatile            Many volatile
Aerosol delivery         Vapor or aerosol delivery
Comparison of Bioterrorism
      Toxins and Chemical Agents
Toxins                              Chemical
Odorless and tasteless              Noticeable odor or taste
Not dermally active*                Dermally active
Legitimate medical uses             No legitimate medical use

Many effective immunogens           Poor immunogens


  * Exceptions, trichothecene (T-2) mycotoxins
II. Methods of Spread
Modes of Exposure / Routes Of Entry

Inhalation
    Inhalation of spores, droplets and aerosols
    Powder
    Spray - Small scale
           - Large scale
    Explosive
    Pulmonary infection is by far most effective
Ingestion
   Food
      Potentially significant route of delivery
      Secondary to either purposeful or accidental exposure to aerosol
   Water
      Capacity to affect large numbers of people
      Dilution factor
      Water treatment may be effective in removal of agents
Inoculation / Contact / Absorption
    Cuts/Abrasions on skin or mucosal membranes
    Vectors (mosquitoes, ticks, fleas and lice)
    Fomites
    Explosive
Delivery via Aerosols (Inhalation)
Aerosol- Small droplet particles composed of many organisms
  dispersed into air and carried by air currents
   Explosive bomb-lets consist of low grade explosive, explode on
     impact and release biological agent which disseminates as aerosol
   Generators have biological agents filled in a pressure chamber
     and are released through a nozzle
   Agent may by released during flight over enemy area or covertly
     set up in the target area
Slurred mixture – Spray of Anthrax and Botulinum toxin
Spray tanks can be carried by aircrafts or missile. Tanks contain large
 quantity of agent and can be effective over a large area
Variables altering effectiveness of a delivery system
  Particle size of the agent
  Stability of the agent under desiccating conditions, UV light
  Wind speed, wind direction, and atmospheric stability
Anthrax Transmission
Inhalation
   Spores in Postal envelopes
   Spray
      Aeroplane

      Spray    machine
   Aerosol
      Aerialbombs
Skin inoculation
Ingestion
Smallpox Transmission
Common: Person – to –person by large airborne droplets
    Face-to-face contact (i.e., 6 feet)

    Should be interrupted by mask protection (e.g., NIOSH N-95)

Rare: Airborne over long distance
Rare: As fomites (e.g., Bed linens)
Not transmitted by food
VHF Agents Transmission

From reservoirs to vectors to humans
Less common route
   Contact with infected animal tissues,
     urine, feces, and other excreta
   Via Aerosols
Conclusion

BW agents are easy to acquire, synthesize and use (Poor man’s
  nukes)
   Small amount of agents can kill hundreds of thousands of
     people in a metropolitan area
   Concealment, transportation, and dissemination of biological
     agents relatively easy
BW agents are difficult to detect or protect against; being invisible,
 odorless, and tasteless, dispersal can be performed silently
Transmitted via inhalation, ingestion and inoculation

Contenu connexe

Tendances (20)

Biological warfare
Biological warfareBiological warfare
Biological warfare
 
1.introduction and history of biological warfare agents
1.introduction and history of biological warfare agents1.introduction and history of biological warfare agents
1.introduction and history of biological warfare agents
 
distribution of micro organisms in soil
 distribution of micro organisms in soil distribution of micro organisms in soil
distribution of micro organisms in soil
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Detection of Biofilm
Detection of BiofilmDetection of Biofilm
Detection of Biofilm
 
Mu phage
Mu phage Mu phage
Mu phage
 
Microorganisms in biological warfare
Microorganisms in biological warfareMicroorganisms in biological warfare
Microorganisms in biological warfare
 
Biologicalwarfare9 (2)
Biologicalwarfare9 (2)Biologicalwarfare9 (2)
Biologicalwarfare9 (2)
 
Normal microbial flora
Normal microbial floraNormal microbial flora
Normal microbial flora
 
NEWER TECHNOLOGIES DIAGNOSTIC MICROBIOLOGY
NEWER TECHNOLOGIES DIAGNOSTIC MICROBIOLOGYNEWER TECHNOLOGIES DIAGNOSTIC MICROBIOLOGY
NEWER TECHNOLOGIES DIAGNOSTIC MICROBIOLOGY
 
Bacteriophage, phage typing and application
Bacteriophage, phage typing and applicationBacteriophage, phage typing and application
Bacteriophage, phage typing and application
 
Normal microflora of human body
Normal microflora of  human bodyNormal microflora of  human body
Normal microflora of human body
 
Module 3a culture and staining
Module 3a   culture and stainingModule 3a   culture and staining
Module 3a culture and staining
 
Microbial interaction.pptx
Microbial interaction.pptxMicrobial interaction.pptx
Microbial interaction.pptx
 
Cultivation and assay of viruses
Cultivation and assay of virusesCultivation and assay of viruses
Cultivation and assay of viruses
 
Water borne microorganisms
Water borne microorganismsWater borne microorganisms
Water borne microorganisms
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Bacterial Growth And Metabolism
Bacterial Growth And MetabolismBacterial Growth And Metabolism
Bacterial Growth And Metabolism
 
Microbiology of air
Microbiology of airMicrobiology of air
Microbiology of air
 

Similaire à 2.characteristics of biowarfare agents and their methods of spread

Occupational hazards of(1).pdf CHN, OH nursing
Occupational hazards of(1).pdf CHN, OH nursingOccupational hazards of(1).pdf CHN, OH nursing
Occupational hazards of(1).pdf CHN, OH nursingAnakha38
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSNehaSaini499770
 
diease43.ppt
diease43.pptdiease43.ppt
diease43.pptjoeseu
 
Chapter 5 identification of virus
Chapter 5 identification of virusChapter 5 identification of virus
Chapter 5 identification of virusAlia Najiha
 
Diseases Caused by Viruses_ Khyati Gupta (1).pdf
Diseases Caused by Viruses_ Khyati Gupta (1).pdfDiseases Caused by Viruses_ Khyati Gupta (1).pdf
Diseases Caused by Viruses_ Khyati Gupta (1).pdfKhyatiGupta71
 
Sanotracin RTU Efficacy Data
Sanotracin RTU Efficacy DataSanotracin RTU Efficacy Data
Sanotracin RTU Efficacy Dataesalozzo
 
Chapter 25 Communicable Diseases.pdf
Chapter 25 Communicable Diseases.pdfChapter 25 Communicable Diseases.pdf
Chapter 25 Communicable Diseases.pdfbkbk37
 
Bioterrorism
BioterrorismBioterrorism
BioterrorismShilpa k
 
SCIENCE DLP Form 2 chapter 4 Human health notes
SCIENCE DLP Form 2 chapter 4 Human health notesSCIENCE DLP Form 2 chapter 4 Human health notes
SCIENCE DLP Form 2 chapter 4 Human health notesCHEAHAIJIAMoe
 
Describe and discuss the three focus areas in Healthy People.pdf
Describe and discuss the three focus areas in Healthy People.pdfDescribe and discuss the three focus areas in Healthy People.pdf
Describe and discuss the three focus areas in Healthy People.pdfsdfghj21
 
Human Clinical and Veterinary Parasitology
Human Clinical and Veterinary ParasitologyHuman Clinical and Veterinary Parasitology
Human Clinical and Veterinary ParasitologyDivya Soni
 

Similaire à 2.characteristics of biowarfare agents and their methods of spread (20)

VECTOR CONTROL
VECTOR CONTROLVECTOR CONTROL
VECTOR CONTROL
 
Occupational hazards of(1).pdf CHN, OH nursing
Occupational hazards of(1).pdf CHN, OH nursingOccupational hazards of(1).pdf CHN, OH nursing
Occupational hazards of(1).pdf CHN, OH nursing
 
Sanjay Vector PPT.pptx
Sanjay Vector PPT.pptxSanjay Vector PPT.pptx
Sanjay Vector PPT.pptx
 
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTSSARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
SARS Cov-2 INFECTION AND ITS EMERGING VARIANTS
 
Direct Contact Diseases Due to Viruses
Direct Contact Diseases Due to VirusesDirect Contact Diseases Due to Viruses
Direct Contact Diseases Due to Viruses
 
Infectious diseases
Infectious diseases Infectious diseases
Infectious diseases
 
diease43.ppt
diease43.pptdiease43.ppt
diease43.ppt
 
Chapter 5 identification of virus
Chapter 5 identification of virusChapter 5 identification of virus
Chapter 5 identification of virus
 
Diseases Caused by Viruses_ Khyati Gupta (1).pdf
Diseases Caused by Viruses_ Khyati Gupta (1).pdfDiseases Caused by Viruses_ Khyati Gupta (1).pdf
Diseases Caused by Viruses_ Khyati Gupta (1).pdf
 
covid.pptx
covid.pptxcovid.pptx
covid.pptx
 
Sanotracin RTU Efficacy Data
Sanotracin RTU Efficacy DataSanotracin RTU Efficacy Data
Sanotracin RTU Efficacy Data
 
Chapter 25 Communicable Diseases.pdf
Chapter 25 Communicable Diseases.pdfChapter 25 Communicable Diseases.pdf
Chapter 25 Communicable Diseases.pdf
 
Bioterrorism
BioterrorismBioterrorism
Bioterrorism
 
Communicable Disease Handouts
Communicable Disease HandoutsCommunicable Disease Handouts
Communicable Disease Handouts
 
Virus host infection-module 1.1
Virus host infection-module 1.1Virus host infection-module 1.1
Virus host infection-module 1.1
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
SCIENCE DLP Form 2 chapter 4 Human health notes
SCIENCE DLP Form 2 chapter 4 Human health notesSCIENCE DLP Form 2 chapter 4 Human health notes
SCIENCE DLP Form 2 chapter 4 Human health notes
 
Describe and discuss the three focus areas in Healthy People.pdf
Describe and discuss the three focus areas in Healthy People.pdfDescribe and discuss the three focus areas in Healthy People.pdf
Describe and discuss the three focus areas in Healthy People.pdf
 
Infection
InfectionInfection
Infection
 
Human Clinical and Veterinary Parasitology
Human Clinical and Veterinary ParasitologyHuman Clinical and Veterinary Parasitology
Human Clinical and Veterinary Parasitology
 

Plus de Kamran Afzal, PhD. (20)

Cell injury
Cell injuryCell injury
Cell injury
 
Concept of Infection Control
Concept of Infection ControlConcept of Infection Control
Concept of Infection Control
 
Rheumatic Fever and Rheumatic Heart Disease
Rheumatic Fever and Rheumatic Heart DiseaseRheumatic Fever and Rheumatic Heart Disease
Rheumatic Fever and Rheumatic Heart Disease
 
Fungal biofilm
Fungal biofilmFungal biofilm
Fungal biofilm
 
Crbsi kamran
Crbsi kamranCrbsi kamran
Crbsi kamran
 
Rubella + rabies
Rubella + rabiesRubella + rabies
Rubella + rabies
 
Ricketssia
RicketssiaRicketssia
Ricketssia
 
Chlamydia
ChlamydiaChlamydia
Chlamydia
 
Brucella and mycoplasma
Brucella and mycoplasmaBrucella and mycoplasma
Brucella and mycoplasma
 
Pseudo+acineto
Pseudo+acinetoPseudo+acineto
Pseudo+acineto
 
Klebsiella+proteus+uti
Klebsiella+proteus+utiKlebsiella+proteus+uti
Klebsiella+proteus+uti
 
Filariasis
FilariasisFilariasis
Filariasis
 
Bacillus anthracis
Bacillus anthracisBacillus anthracis
Bacillus anthracis
 
Strep pneumoniae
Strep pneumoniaeStrep pneumoniae
Strep pneumoniae
 
Zoonosis
ZoonosisZoonosis
Zoonosis
 
Sst is and ssis
Sst is and ssisSst is and ssis
Sst is and ssis
 
Cns infections
Cns infectionsCns infections
Cns infections
 
Strongyloides schistosoma
Strongyloides schistosomaStrongyloides schistosoma
Strongyloides schistosoma
 
Cryptosporidium parvum
Cryptosporidium parvumCryptosporidium parvum
Cryptosporidium parvum
 
Tinea dermatophytes
Tinea   dermatophytesTinea   dermatophytes
Tinea dermatophytes
 

2.characteristics of biowarfare agents and their methods of spread

  • 1. Potential Biowarfare Agents and their Methods of Spread Dr Kamran Afzal Classified Pathologist and Microbiologist
  • 3. Potential BW Agents: CDC Category A FEATURES AGENTS  Easily disseminated or  Anthrax transmitted person -  Plague person  Smallpox  High mortality – major  Tularemia public health impact  Viral  Public panic and social haemorrhagic fevers disruption  Botulinum toxin  Special action for public health preparedness
  • 4. Potential BW Agents: CDC Category B FEATURES AGENTS  Moderately easy to  Brucellosis disseminate Q fever  Moderate morbidity, low mortality  Glanders & melioidosis  Require enhancement of  VEE, EEE and WEE diagnostic capacity and  Enteric pathogens surveillance  Other toxins
  • 5. Potential BW Agents: CDC Category C FEATURES AGENTS  Emerging agents  Nipah virus  Availability  Hantaviruses  Easy to produce and  Tickborne HF disseminate  Potential for high mortality  Tickborne encephalitis and morbidity  Yellow fever  MDR-TB
  • 6. Desirable Features of Biological Agents to be used as Biological Weapons Less expensive Available Easily transported/concealed and dispersed Incubation period “Hides Tracks” of perpetrator Modifiable (resistance, virulence) Produce ‘anxiety factor’, over-loading health services Produce social disruption, reduce productivity Impact on morale, create epidemic
  • 7. Characteristics of BW Agent Infective dose should be low Should be highly contagious Should be stable and robust Can be aerosolized (1-10 µm) Survives sunlight, drying, heat Cause lethal or disabling disease Person-to-person transmission Should consistently produce given effect, death or disease Should have a short and predictable incubation period
  • 8. Characteristics of BW Agent The agent should be amenable to easy and economical mass production Storage methods should be available Target population should have little or no natural or acquired immunity Prophylaxis against the agent should not be available to the target population Little or no treatment for the disease caused by the agent should be available The aggressor should have means to protect its own forces and population
  • 9. Characteristics of BW Agent It should be capable of efficient dissemination Stable during dissemination. If it is to be delivered via an aerosol, it must survive and remain stable in air until it reaches the target population If it cannot be delivered via an aerosol, living vectors (e.g. fleas, mosquitoes or ticks) should be available for dispersal of some form of infected substrate After delivery, the agent should have a low persistence, surviving only for a short time, thereby allowing a prompt occupation of the attacked area by the aggressor’s troops
  • 10. Aerosol : Infectivity Relationship Particle Size Infection The ideal aerosol (Micron, Mass Severity Median contains a homogeneous Diameter) Less population Severe of 2 or 3 micron 18-20 particulates that contain one or more 15-18 viable organisms 7-12 Maximum human 4-6 (bronchioles) respiratory infection is a particle that falls within 1-5 (alveoli) 1 to 5 micron size More Severe Source: San Diego Medical Society
  • 11. Uniqueness of Biological Attacks Responders – medical Response System – untested Medical System may be a target Biological  Onset - incubation, primary cases  Secondary cases – contagiousness, contamination
  • 12. Difficulties in use Incubation period ranges from hours to days Rain, sunlight and temp extremes reduce the virulence Natural and acquired immunity against pathogens make it impossible to predict the exact number of casualties from any BW attack Consequently, BW today is primarily for harassment and special operations
  • 13. Potential BW Agents Bacteria Mode of I.P. Mortality Vaccine Treatment Transmission Bacillus anthracis A, D, I 1–7 5-100 + E (Anthrax) Brucella group A, D, I 5-21 2-6 + E (Brucellosis) Francisella tularensis A, D, I, V 1-10 <30 ++ E (Tularemia) Yersinia pestis A, V 2-6 25-100 +++ E (Plague) Vibrio cholerae (Cholera) I 1-5 15-90 +++ E Corynebacterium diphtheriae A, D 2-5 5-12 +++ E (Diphtheria) A - Aerosol D - Direct contact I - Ingestion V - Vector E - Effective treatment available N - Non-specific treatment
  • 14. Potential BW Agents Salmonella typhi I 6-21 7-14 +++ E (Typhoid fever) Rickettsiae V 6-15 10-40 +++ E Rickettsia prowazeki (Epidemic or louse-borne typhyus) Rickettsia mooseri V 6-14 2-5 E (Endemic or flea-borne typhyus) - Rickettsia rickettsii V 3-10 30 (Approx) E (Rocky Mountain spotted fever) - Coxiella burneti A, I 14-21 <1 ++ E (Q fever) A - Aerosol D - Direct contact I - Ingestion V - Vector E - Effective treatment available N - Non-specific treatment
  • 15. Potential BW Agents Viruses Mode of I.P. Mortality Vaccine Treatment Transmission Group A Arboviruses V 4-24 60 - N Eastern equine encephalitis (EEE) (Approx) Venezuelan equine encephalitis V 4-24 <1 ++ N (VEE) Group B Arboviruses V (mosquito) 4-24 - - N St. Louis encephalitis Japanese B encephalitis V (mosquito) 5-15 10-80 ++ N Russian spring-summer V (tick) 7-14 3-40 + N encephalitis (RSSE) Yellow fever V (mosquito) 3-6 5-40 +++ N A - Aerosol D - Direct contact I - Ingestion V - Vector E - Effective treatment available N - Non-specific treatment
  • 16. Potential BW Agents Dengue virus V (mosquito) 4-10 <1 - N Ungrouped Arbovirus V (mosquito) 4-6 1 - N Rift Valley fever virus Poxvirus A, D 7-16 1-35 +++ N Variola virus (Smallpox) Myxovirus A, D 6-365 100 ++ E Rabies virus Influenza virus A, D 1-2 - + H5N1 E A - Aerosol D - Direct contact I - Ingestion V - Vector E - Effective treatment available N - Non-specific treatment
  • 17. Potential BW Agents Fungi A, D 10-21 1-51 - E Coccidioides immitis (Coccidioidomycosis) Histoplasma A 5-18 - - E capsulatum A - Aerosol D - Direct contact I - Ingestion V - Vector E - Effective treatment available N - Non-specific treatment
  • 18. Potential BW Toxins NAME SOURCE EFFECTS Botulinum toxin A Clostridium botulinum Dizziness, sore throat, and dry mouth followed by paralysis Death by suffocation (respiratory paralysis) or heart failure Ricin Castor bean plant Nausea, vomiting, bloody diarrhea, and drowsiness Death by kidney failure (uremia) Saxitoxin Dino-flagellates Tingling around face, loss of sensation (Shellfish toxin) in extremities Death by paralysis Tricothecenes- Fungus Nausea, vomiting, diarrhea myco toxins Death by internal hemorrhaging
  • 19. Comparison of Bioterrorism Toxins and Chemical Agents Toxins Chemical Natural origin Man-made Generally more toxic Generally less toxic Difficult, small-scale Large-scale, industrial production production None volatile Many volatile Aerosol delivery Vapor or aerosol delivery
  • 20. Comparison of Bioterrorism Toxins and Chemical Agents Toxins Chemical Odorless and tasteless Noticeable odor or taste Not dermally active* Dermally active Legitimate medical uses No legitimate medical use Many effective immunogens Poor immunogens * Exceptions, trichothecene (T-2) mycotoxins
  • 21. II. Methods of Spread
  • 22. Modes of Exposure / Routes Of Entry Inhalation  Inhalation of spores, droplets and aerosols  Powder  Spray - Small scale - Large scale  Explosive  Pulmonary infection is by far most effective
  • 23. Ingestion Food  Potentially significant route of delivery  Secondary to either purposeful or accidental exposure to aerosol Water  Capacity to affect large numbers of people  Dilution factor  Water treatment may be effective in removal of agents
  • 24. Inoculation / Contact / Absorption  Cuts/Abrasions on skin or mucosal membranes  Vectors (mosquitoes, ticks, fleas and lice)  Fomites  Explosive
  • 25. Delivery via Aerosols (Inhalation) Aerosol- Small droplet particles composed of many organisms dispersed into air and carried by air currents Explosive bomb-lets consist of low grade explosive, explode on impact and release biological agent which disseminates as aerosol Generators have biological agents filled in a pressure chamber and are released through a nozzle Agent may by released during flight over enemy area or covertly set up in the target area Slurred mixture – Spray of Anthrax and Botulinum toxin
  • 26. Spray tanks can be carried by aircrafts or missile. Tanks contain large quantity of agent and can be effective over a large area Variables altering effectiveness of a delivery system Particle size of the agent Stability of the agent under desiccating conditions, UV light Wind speed, wind direction, and atmospheric stability
  • 27. Anthrax Transmission Inhalation Spores in Postal envelopes Spray  Aeroplane  Spray machine Aerosol  Aerialbombs Skin inoculation Ingestion
  • 28. Smallpox Transmission Common: Person – to –person by large airborne droplets  Face-to-face contact (i.e., 6 feet)  Should be interrupted by mask protection (e.g., NIOSH N-95) Rare: Airborne over long distance Rare: As fomites (e.g., Bed linens) Not transmitted by food
  • 29. VHF Agents Transmission From reservoirs to vectors to humans Less common route Contact with infected animal tissues, urine, feces, and other excreta Via Aerosols
  • 30. Conclusion BW agents are easy to acquire, synthesize and use (Poor man’s nukes) Small amount of agents can kill hundreds of thousands of people in a metropolitan area Concealment, transportation, and dissemination of biological agents relatively easy BW agents are difficult to detect or protect against; being invisible, odorless, and tasteless, dispersal can be performed silently Transmitted via inhalation, ingestion and inoculation

Notes de l'éditeur

  1. )